Howard Berman's most recent trade in Coya Therapeutics Inc was a trade of 150,602 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 9, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Coya Therapeutics Inc | Howard Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 150,602 | 150,602 | - | - | Stock Option (right to buy) | |
Coya Therapeutics Inc | Howard Berman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 163,663 | 163,663 | - | - | Stock Option (right to buy) | |
Coya Therapeutics Inc | Berman Howard | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 189,680 | 189,680 | - | - | Stock Option (right to buy) | |
Coya Therapeutics Inc | Howard Berman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 165,000 | 165,000 | - | - | Stock Option (right to buy) |